REGENERX BIOPHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q2 2013 to Q1 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Regenerx Biopharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q2 2013 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Debt-to-equity for the quarter ending March 31, 2023 was -114 %, a 33.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2023 -114 +58.1 +33.7% Mar 31, 2023
Q4 2022 -122 +38.3 +23.9% Dec 31, 2022
Q3 2022 -133 +15.8 +10.6% Sep 30, 2022
Q2 2022 -148 -16.9 -12.9% Jun 30, 2022
Q1 2022 -172 -58.3 -51.1% Mar 31, 2022
Q4 2021 -160 -42.3 -35.8% Dec 31, 2021
Q3 2021 -149 -28.3 -23.4% Sep 30, 2021
Q2 2021 -131 -1.26 -0.97% Jun 30, 2021
Q1 2021 -114 +28.1 +19.8% Mar 31, 2021
Q4 2020 -118 +27.5 +18.9% Dec 31, 2020
Q3 2020 -121 +20.4 +14.5% Sep 30, 2020
Q2 2020 -130 +4.69 +3.49% Jun 30, 2020
Q1 2020 -142 -16.3 -12.9% Mar 31, 2020
Q4 2019 -146 -17.3 -13.5% Dec 31, 2019
Q3 2019 -141 -18.4 -15% Sep 30, 2019
Q2 2019 -135 -19.8 -17.2% Jun 30, 2019
Q1 2019 -126 -16.4 -15% Mar 31, 2019
Q4 2018 -128 -22.5 -21.2% Dec 31, 2018
Q3 2018 -123 -14.5 -13.5% Sep 30, 2018
Q2 2018 -115 -2.8 -2.5% Jun 30, 2018
Q1 2018 -110 +6.85 +5.89% Mar 31, 2018
Q4 2017 -106 +6.85 +6.08% Dec 31, 2017
Q3 2017 -108 +2.73 +2.46% Sep 30, 2017
Q2 2017 -112 -2.61 -2.39% Jun 30, 2017
Q1 2017 -116 -9.85 -9.25% Mar 31, 2017
Q4 2016 -113 +0.56 +0.49% Dec 31, 2016
Q3 2016 -111 +10.2 +8.44% Sep 30, 2016
Q2 2016 -109 +26.2 +19.3% Jun 30, 2016
Q1 2016 -107 +41.5 +28% Mar 31, 2016
Q4 2015 -113 +45.8 +28.8% Dec 31, 2015
Q3 2015 -121 +26.4 +17.9% Sep 30, 2015
Q2 2015 -136 -5.06 -3.88% Jun 30, 2015
Q1 2015 -148 -24.6 -19.9% Mar 31, 2015
Q4 2014 -159 -50.4 -46.3% Dec 31, 2014
Q3 2014 -147 -32.1 -27.9% Sep 30, 2014
Q2 2014 -130 -15 -13% Jun 30, 2014
Q1 2014 -123 Mar 31, 2014
Q4 2013 -109 Dec 31, 2013
Q3 2013 -115 Sep 30, 2013
Q2 2013 -115 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.